Benign Conditions

Latest News

FDA approves pivmecillinam tablets for uncomplicated UTIs
FDA approves pivmecillinam tablets for uncomplicated UTIs

April 24th 2024

The approval is based on 3 clinical trials evaluating the efficacy of different pivmecillinam dosing regimens in comparison with either placebo, another oral antibacterial drug, or ibuprofen.

Blur image of hospital corridor | Image Credit: © whyframeshot - stock.adobe.com
UTI vaccine shows efficacy, safety in men and women

April 10th 2024

blur image background of corridor in hospital or clinic image | © whyframeshot - stock.adobe.com
The dilemma of using disposable scopes

March 19th 2024

Trial progresses of RECCE 327 for UTI and urosepsis
Trial progresses of RECCE 327 for UTI and urosepsis

March 14th 2024

AUGS Clinical Consensus Statement on Postoperative Urinary Retention
AUGS Clinical Consensus Statement on Postoperative Urinary Retention

February 26th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.